Physician profile
Gennaro Giustino
NPI 1174985113
$134,637.78
in general payments reported to CMS, 2019-2025
30 companies · $99K in 2025
The $99K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,719 · 2020: $425 · 2021: $1,194 · 2022: $2,345 · 2023: $20K · 2024: $7,679 · 2025: $99K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Travel and Lodging: $25K · Food and Beverage: $19K · Grant: $13K · Honoraria: $900 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $68,053.13 |
| Travel and Lodging | $25,310.84 |
| Food and Beverage | $19,090.76 |
| Grant | $13,000.00 |
| Honoraria | $900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $91,697.82 | 2023-2025 | Pascal, Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $25,890.40 | 2022-2025 | Corevalve Evolut R, Chocolate Pta Balloon Catheter |
| E.R. Squibb & Sons, L.L.C. | $3,829.04 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $2,303.79 | 2023-2025 | Navitor, Amplatzer, Pressurewire |
| Shockwave Medical, INC | $2,274.79 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals Lp | $1,330.89 | 2020-2023 | Farxiga |
| Abiomed | $1,255.77 | 2023-2024 | Impella |
| Angiodynamics, INC. | $1,191.08 | 2024-2025 | Alphavac, Angiovac |
| Terumo Medical Corporation | $696.59 | 2022-2023 | Metacross Otw, Angio-Seal, Glidesheath Slender |
| Cardiovascular Systems INC. | $683.36 | 2020-2022 | |
| Boston Scientific Corporation | $525.04 | 2022-2023 | Mdu5 Plus Sterile Bag, Filterwire Ez |
| Aop Health US, LLC | $509.74 | 2025 | Rapiblyk |
| Cardiva Medical, INC. | $499.85 | 2022-2025 | Savvywire, Cardiva Vascade 5f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Bard Peripheral Vascular, INC. | $467.71 | 2022-2023 | Venovo, Crosser Iq, Lutonix Drug Coated Balloon |
| Amgen INC. | $293.93 | 2021-2023 | Repatha |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $207.04 | 2023-2024 | Kengreal, Cleviprex |
| Cook Medical LLC | $146.69 | 2023-2024 | Advance, Torcon Nb, Zilver Vena |
| Philips North America LLC | $142.10 | 2022-2025 | Extended Holter |
| Teleflex LLC | $134.93 | 2022-2024 | Trapliner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.76 | 2023-2024 | Lifevest |
| Cagent Vascular INC | $106.76 | 2023 | Serrantor |
| Lantheus Medical Imaging, INC. | $98.86 | 2020-2021 | |
| Pfizer INC. | $91.94 | 2022-2023 | |
| W. L. Gore & Associates, INC. | $31.25 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.44 | 2019 | |
| Biotronik INC. | $22.43 | 2022 | |
| Asahi Intecc USA, INC. | $22.41 | 2023 | Asahi Ptca Guide Wire |
| Novo Nordisk INC | $16.94 | 2022 | |
| Siemens Medical Solutions USA, INC. | $16.83 | 2024 | Acuson Sc2000 Diagnostic Ultrasound System |
| Reflow Medical INC | $12.60 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gennaro Giustino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.